Home » Newsletters » BioWorld Science

BioWorld Science

April 11, 2005

View Archived Issues

Interleukin-8 inhibition reduces ischemia-reperfusion injury following lung transplantation

Good PK profile reported for sublingual tacrolimus after lung transplantation

Gilead Sciences' JTK-303 license agreement gets FTC clearance

Phase I study evaluates Rexin-G for metastatic colon and pancreatic cancer

Good efficacy and safety profile for NIP-151 in canine model of atrial fibrillation

New approvals for Taxus Express2 stent

GTC cleared for new study of ATryn in hereditary antithrombin deficiency

Reveromycin A inhibits osteolytic bone metastasis

Toray and Takeda to jointly develop compound for frequent urination

Phase II trial of EP-2104R for blood clot detection using MRI

Yondelis studied in phase III trial in ovarian cancer patients

BioMarin initiates phase III of Phenoptin for PKU

Phase III trial fails to show benefit of prasterone in women with SLE

No merger for Senetek and IGI

AD-452 for rheumatoid arthritis completes phase IIa study

Inncardio to acquire Cengent Therapeutics

Priority review and new development agreement for Enhanze SC

Takara Bio and MolMed sign AIDS gene therapy development agreement

Protox Therapeutics exercises lung cancer license option

U.K. Government funding for phase III trial of PRO-2000

Src kinase inhibitor as a potential preventative therapy for metastasis to bone

Novel CYP17 inhibitor shows promise as a treatment for prostate cancer

Discovery of a novel 17beta-HSD1 inhibitor with antitumor activity

Lunesta now available

sanofi-aventis and DNDi collaborate on malaria drug development

New agents for Alzheimer's dementia reported in patent literature

Recent Merck patents describe new agents for the treatment of osteoporosis

Novel anticancer therapeutic agents disclosed in recent patents

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 4, 2025.
UK Biobank delivers largest metabolomics dataset of 500K profiles
BioWorld Science
It’s the biological resource that keeps on giving, and now UK Biobank has released the final tranche of data on the levels of 249 metabolites in the blood of its...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...